Report : Middle East and Africa Sleep Apnea Diagnostics Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Polysomnography (PSG) Device, Home Sleep Testing Devices, Oximeter, Actigraphy Monitoring Device, and Sleep Apnea Screening Device) and End User (Hospitals and Sleep Laboratories and Home Care Settings)
Oximeter is Expected to be the Fastest Growing Segment During the Forecast Period 2021–2028
According to a new market research study on “Middle East & Africa Sleep Apnea Diagnostics Market to 2028 – COVID-19 Impact and Regional Analysis and Forecast by Product and End User,” is expected to reach US$ 27.01 million by 2028 from US$ 20.88 million in 2021. The market is estimated to grow at a CAGR of 3.7% from 2021 to 2028. The report provides trends prevailing in the Middle East & Africa sleep apnea diagnostics market along with the drivers and restraints pertaining to the market growth. Expanding technological developments, strengthen prevalence of sleep apnea, and scaling scope of telemedicine are the major factor driving the growth of the Middle East & Africa sleep apnea diagnostics market. However, expensive cost of diagnosis of sleep apnea hinder the growth of Middle East & Africa sleep apnea diagnostics market.
The coronavirus has had a significant impact in the Middle East & Africa. Iran was one of the pandemic's first victims, with fatal cases reported as early as March 2020. Middle East & Africa countries, saw three waves of the pandemic, with a few outliers. However, due to insufficient diagnosis and reporting systems in some countries, a comparable cross-country examination of infection intensity is challenging. The relative frequency of testing can be used as an indirect indicator of the diagnostic system's performance. The United Arab Emirates (UAE) and Bahrain have been regional leaders in terms of testing, outperforming some advanced economies. Obstructive sleep apnea and other sleep disorders have comorbidities with severe acute respiratory syndrome coronavirus 2 infection, which are linked to poor outcomes. However, the prevalence of obstructive sleep apnea and its association with outcomes in COVID-19 patients is little understood, and the significance of other sleep disorders is uncertain. There appears to be a clear link between being overweight or obese and the probability of hospitalization and necessitating treatment in intensive care units for people with coronavirus illness 2019 (COVID-19), which is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (ICUs). According to new research, obese people under the age of 60 are more likely to be hospitalized. Obesity prevalence rates are among the highest in the world in the Middle East. Given the exponential rise in the incidence of obesity, knowing how obesity increases the risk of severe COVID-19 infection is crucial for developing effective interventional and preventative treatments for this novel coronavirus.
The Middle East & Africa sleep apnea diagnostics market is segmented on the basis of product, end user, and country. Based on product, the market is segmented into polysomnography (PSG) device, home sleep testing devices, oximeter, actigraphy monitoring device, and sleep apnea screening device. In 2021, polysomnography (PSG) device segment held the largest share in the market, and oximeter is expected to be the fastest growing segment during the forecast period. Further based on oximeter, the market is segmented into finger tip oximeter, handheld oximeter, wrist-worn oximeter, and tabletop oximeter. In 2021, finger tip oximeter segment held the largest share in the market, and it is also expected to be the fastest growing segment during the forecast period. Based on end user, the market is bifurcated into hospitals and sleep laboratories and home care settings. In 2021, hospitals and sleep laboratories segment held the largest share in the market, and home care settings is expected to be the fastest growing segment during the forecast period. Similarly Based on country the market is segmented into South Africa, Saudi Arabia, the UAE, and Rest of MEA. In 2021, South Africa held the largest share in the market, and it is also expected to be the fastest growing country during the forecast period.
ResMed, Inc.; Nihon Kohden Corporation LLC; SOMNOmedics GmbH; Cleveland Medical Devices Inc.; Koninklijke Philips N.V.; Natus Medical Incorporated; Itamar Medical Ltd.; and Compumedics Limited are among the leading companies in the Middle East & Africa sleep apnea diagnostics market. The companies are focused on adopting organic growth strategies such as product launches and expansions to sustain their position in the dynamic market. For instance, The Company exhibited respiratory products in MAIK Münchner Außerklinischer Intensiv Kongress - Munich, Germany. Drive DeVilbiss Germany and Drive DeVilbiss International exhibited and demonstrated latest product developments from Respiratory category.
Contact Us
Contact Person: Sameer Joshi
Phone: +1-646-491-9876
Email Id: sales@businessmarketinsights.com